Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
TG-1042 by Ascend Biopharmaceuticals for Cutaneous B-Cell Lymphoma: Likelihood of Approval
TG-1042 is under clinical development by Ascend Biopharmaceuticals and currently in Phase II for Cutaneous B-Cell Lymphoma. According to GlobalData,...
Data Insights
TG-1042 by Ascend Biopharmaceuticals for Basal Cell Carcinoma (Basal Cell Epithelioma): Likelihood of Approval
TG-1042 is under clinical development by Ascend Biopharmaceuticals and currently in Phase II for Basal Cell Carcinoma (Basal Cell Epithelioma)....